Fujinami sarcoma virus (FSV) genome codes for the gag-fps fusion protein FSV-P130. The amino acid sequence of the 3' one-third portion in v-fps is partially homologous to the 3' half of pp6jsrc, or the kinase domain, but the sequence of the 5' portion is unique to v-fps. To identify a possible domain structure in the v-fps sequence responsible for cell transformation, we constructed various deletion mutants of FSV with molecularly cloned viral DNA. Their transforming activities were assayed by measuring focus formation on chicken embryo fibroblasts and rat 3Y1 cells and tumor formation in chickens. The mutants carrying a deletion at the 3' portion in v-fps, the kinase domain, lost transforming activity. The mutants carrying an approximately 1-kilobase deletion within the 5' portion of the v-fps sequence retained focus-forming activity and tumorigenicity in the chicken system, but the efficiency of focus formation was about 10 times lower than that of the wild type. The morphology of these transformed cells was distinct from that observed in cells infected with wild-type FSV. Furthermore, these mutants could not transform rat 3Y1 cells, although wild-type FSV DNA transformed rat 3Y1 cells at a high frequency. The mutants carrying a larger deletion in the 5' portion offps completely lacked the transforming activity. These results suggest that the 3' portion of the v-fps sequence is necessary but not sufficient for cell transformation and that the 5' portion of v-fps has a role in the transforming activity.
Fujinami sarcoma virus (FSV) (15) is a replicationdefective avian retrovirus capable of transforming chicken embryo fibroblasts (CEFs) and rat 3Y1 cells in vitro and acutely inducing tumors in chickens (19, 27) . The FSV genome encodes a 130-kilodalton (kDa) protein (P130) which is a fusion product between amino acid sequences encoded by gag information remaining on the FSV genome and amino acid sequences encoded by the acquired cellular gene cfpslfes in chickens (28, 42, 43) . The FSV-P130gag-AP' has tyrosine-specific protein kinase activity (12, 18, 37, 38) . It has been shown that the c-fpslfes sequence encodes a normal cellular protein of 98 kDa, NCP98, which was detected by immunoprecipitation from normal, uninfected chicken bone marrow cell extract with rat serum against v-fps product (33) . Since the molecular size of the FSV-fps product, 99 kDa, is almost the same as that of NCP98, FSV may contain the major portion of the c-fpslfes coding sequence (42) . Indirect immunofluorescence and subcellular fractionation experiments showed that the majority of P130gag-fps and its associated protein kinase activity is localized in the cytoplasm in FSV-transformed cells (13) .
The v-fps sequences of the different isolates of avian sarcoma virus, FSV, PRCII (3, 6) , PRCIV (2, 6, 53) , UR1 (1, 50) , and 16L (35) , are highly related, as has been shown by RNase T, fingerprinting, hybridization, and nucleotide sequence analysis (36) . Recently, PRCII-fps has been found to carry a deletion mutation within the FSV-fps sequence (5, 21) . Since PRCII is weakly tumorigenic when compared with FSV (10) , these facts raised the possibility that there might be a correlation between the fps content of viruses and their transforming activities. Therefore, to improve our understanding of the mechanism of oncogenesis by these avian sarcoma viruses, it is desirable to determine the domain (44) . A subclone pBR-F16 contains a 1.6-kilobase BamHI fragment of FSV which consists of two tandemly repeated LTRs and a portion of the gag sequence in the BamHI site of pBR322. The (11) to close the plasmid, and used to transform Escherichia coli HB101 (7) . The plasmid DNAs of ampicillin-resistant colonies were prepared by a smallscale rapid-boiling method (20) and screened for the desired construct by restriction endonuclease mapping. Closed circular plasmid DNA of the FSV mutant was isolated by a large-scale rapid-boiling method (20) Transfection assay and virus infection. The procedure for focus assay on CEFs was essentially the same as described previously (48) . Transfections were performed by the DEAE-dextran method (22) : for standard assay, 106 CEFs in 1 ml of medium per 60-mm dish were treated with 100 ng of FSV plasmid clone DNA, 1 ,ug of helper virus plasmid (pYAV) DNA, and 2 ,ug of DEAE-dextran for 2 h at 37°C in a 5% CO2 incubator. After treatment, the medium was aspirated, and the cells were treated with 22.5% dimethyl sulfoxide-containing medium for 4 min at room temperature. The medium was then replaced with fresh medium. The next day, the cultures were overlaid with 5 ml of hard agar solution. Foci of transformed CEFs were observed and counted under a microscope at 7 days after transfection.
Transfections of rat 3Y1 cells were performed as described previously (31) , with some modifications as follows: 500 ng of DNA, 20 pug of calf thymus DNA, and 25 ,ul of 2.5 M CaCl2 were added to 0.5 ml of the transfection buffer (140 mM NaCl, 5 mM Na2HPO4, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES] [pH 6.95]). After about 2 h, Ca2+-coprecipitated DNA was added to 1 x i05 to 2 x 105 cells in a 60-mm dish. The culture was treated with chloroquine at a final concentration of 100 ,uM and incubated for 4 h in a 5% CO2 incubator. After treatment, the medium was replaced with fresh medium. Medium was changed every 3 to 4 days, and foci were scored at 5 to 6 weeks after transfection.
Virus infection was performed as described by Hanafusa (17) .
Radiolabeling, preparation of cell extract, and im- (50 ,ul) of cell extracts were incubated with S ,u of the appropriate sera for 60 min on ice. Protein A-Sepharose CL4B (20 ,ul) (Pharmacia) (a 50% [vol/vol] slurry in modified RIPA buffer) was added and mixed for 60 min on ice. The Sepharose was precipitated by centrifugation and washed five times with modified RIPA buffer and twice with 0.05 M Tris hydrochloride (pH 7.5). The pellet was then suspended in 60 ,u1 of electrophoresis sample buffer (12) and boiled for 3 min. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was carried out in 8.5% slab gels as described by Laemmli (26) .
Protein kinase assay. A 10-pI portion of 50 mM HEPES-KOH (pH 7.5)-10 mM MnCl2-10-7 M [-y-32P]ATP (about 3,000 Ci/mmol) prepared by the method of Walseth and Jonson (49) was added to the packed pellet of immunocomplex-protein A-Sepharose. The tube was incubated for 30 min at 37°C, and the reaction was stopped by the addition of 40 ptl of electrophoresis sample buffer.
Phosphoamino acid analysis. Phosphorylated proteins were electroeluted from the appropriate gel slices, precipitated with 10% (wt/vol) trichloroacetic acid, and hydrolyzed in 6 N HCl at 105°C for 1.5 h (41). The hydrolysates were lyophilized and dissolved in 5 pI of electrophoresis buffer (formic acid-acetic acid-H20 [25:87:887, vol/vol], pH 1.9) containing standard marker phosphoamino acids, followed by electrophoresis on cellulose-coated thin-layer plates as the first dimension. The standard marker phosphoamino acids were a gift from K. Segawa (Institute of Medical Science, University of Tokyo, Japan). Ascending chromatography in the second dimension was performed in isobutyric acid-0.5 M NH40H (5:3, vol/vol).
RESULTS
Construction of FSV deletion mutants. To identify which portion of the FSV genome plays an important role in transformation, we carried out a deletion analysis of the cloned viral genome. For preparation of deletion mutants of FSV and for examination of the biological activities of the mutants, a plasmid containing a single copy of nonpermuted FSV DNA is very convenient. Therefore, we first constructed p4L-FSV (Fig. 1) known that focus formation of CEFs by DNA transfection is induced by virions produced by cells cotransfected with helper virus DNA and replication-defective transforming virus DNA (8). Since we planned to assay the biological activities of these FSV mutants in a chicken system as well as in a rodent system, the sequence ranging from the 5' LTR to the SstII site (543 nucleotides) in the gag sequence, which is important for packaging viral RNA into virus particles (24, 40) , was retained in all of the deletion mutants. Furthermore, for the preparation of FSV mutants, DNA segments in the gag-fps sequence were deleted without changing the reading frame in the genome (42) . The procedure for construction of the FSV deletion mutants is described in Materials and Methods, and their genome structures and the products predicted from the new open reading frames are summarized in Fig. 2 . Characteristics of the deletion mutants used in the present work were as follows. (i) 3'-fps deletion mutants pS43 and pP8. The 112-kDa product of pS43 is expected to lack a carboxyterminal portion of the kinase domain. The 73-kDa product of pP8 lacks the entire kinase domain. (ii) 5'-fps deletion mutants pP34 and pPl. The 103-and 95-kDa products of these mutants lack 247 and 316 amino acid residues, respectively, in the amino-terminal half offps peptide. The deleted region is predicted from the sequence to be highly hydrophilic (30, 42, 54) . (iii) Mutants with the deletion of a portion of the gag and 5'-fps sequence pClF221, pTEF2.7, and pTEF2.1. The deduced order of gag and 5'-fps contents among the three mutants was pClF221 > pTEF2.7 > pTEF2.21. (iv) Mutants with deletion of a portion of gag and most of thefps sequence pTEF2.1 and pS74. The product of pTEF2.1 consists of p19 protein and about one-fourth of the kinase domain. The product of pS74 consists of a portion of p19 protein and the carboxy-terminal half of the kinase domain, including the phosphoacceptor tyrosine (1,073-amino acid residue).
The structure of each constructed FSV plasmid was confirmed to be the desired one by restriction enzyme mapping analysis (data not shown).
Transforming activities of FSV mutants. Deletion mutants of FSV summarized in Fig. 2 (Table 1) . On the other hand, none of the deletion mutants except for pP34 and pPl demonstrated transforming activity on CEFs. These mutants, pP34 and pPl, with deletion of the 5' half of the v-fps sequence (Fig. 2) , had a transforming activity five to ten times lower than that of wild-type p4L-FSV. All mutants, including pP34 and pPl, completely lacked transforming activity on rat 3Y1 cells. To confirm that pP34 and pPl, which are biologically active towards CEFs, have no oncogenic activity on rat 3Y1 cells, the amount of plasmid DNA used in transfection experiments was increased 10-fold compared with the amount used in the standard experiments shown in Table 1 ' 'J, the transforming activities of pP34, pPl, and p4L-FSV more quantitatively, the dose-response curves (Fig. 3) and pPl are more subtle than those formed by p4L-FSV, but the morphological changes are quite evident in comparison with normal or pYAV-transfected CEFs (Fig. 4) . These cells were refractile but less fusiform shaped, and the morphology was similar to that of PRCII-transformed cells (Fig. 4E) (16 (Fig. 5, lanes f  and g) . The sizes of these proteins were essentially the same as those calculated from the deduced amino acid sequences of pP34 and pPl. We also detected P103 and P95 as phosphoproteins in in vivo 32P1-labeled cell extracts (data not shown).
The amounts of FSV-specific proteins in pP34-and pPltransformed cells appear to be similar, since the labeled cell extracts were prepared from approximately the same number of transformed cells. Furthermore, the relative intensities of the bands corresponding to FSV-specific protein between [35S]methionine labeling and in vitro autophosphorylation were similar in P130, P103, and P95. These results suggest that the specific activity of their protein kinases is at approximately the same level. FSVspecific proteins of chicken tumors induced by mutant viruses were also examined by in vitro autophosphorylation reaction. P103 and P95 were detected as autophosphorylated proteins, indicating that tumors were induced by the mutant viruses themselves but not by so-called recovered forms of FSV mutants which have acquired a c-fpslfes sequence corresponding to the deleted region.
The amino acid residues phosphorylated in vitro on FSVspecific proteins were checked by two-dimensional phosphoamino acid analysis. The spots of phosphoamino acids comigrate on a cellulose-coated thin-layer plate with standard phosphotyrosine (Fig. 6) . Thus, P103gag-fPs and P95gag-fps were exclusively phosphorylated at tyrosine residues.
In summary, Fig. 7 indicates a schematic diagram of the gene products of wild-type and deletion mutants of FSV.
DISCUSSION
FSV-P1309'9-fP' appears to be structurally separable into three regions: the gag region (amino acid residues 1 to 309), the fps-specific region (residues 310 to 888), and the kinase domain (residues 889 to 1,182) (42) . Recently, Foster and Hanafusa (14) have shown that an FSV mutant which lacks the gag sequences is capable of transforming fibroblasts and inducing tumors in chickens. Therefore, the gag region of FSV-P130 is not required for cell transformation. The carboxy-terminal region of FSV-P130 has been reported to possess kinase activity (51) . Furthermore, insertion mutagenesis in this kinase domain of FSV-P130 abolished the capacity of the FSV genome to induce cell transformation (47) . Thus, this kinase domain appears to be crucial for transforming activity. In the present study, we have shown that thefps-specific portion also has an important function in the transforming ability of FSV genome.
Two deletion mutants of P34-FSV and P1-FSV which have similar deletions 740 and 950 base pairs long, respectively, within the fps-specific portion showed three common characteristics: (i) low efficiency of focus formation on CEFs, (ii) lack of transforming activity on rat 3Y1 cells, and (iii) morphological alteration of transformed foci on CEFs distinct from that induced by wild-type FSV. Since these independently prepared mutants showed quite similar properties to each other, these properties appear to be closely related to the absence of this 5'-fps sequence in the FSV genome.
Focus-forming activities of P34 and P1 mutants on CEFs were about 10-fold less than those of wild-type FSV (Fig. 3) . It seems unlikely that this difference can be explained in terms of a reduced level of transcription or translation of the genomes of these mutants, because we did not modify any portion of the gag or 5' and 3' LTR regions, which are important for such functions. We cannot completely rule out the possibility of a decrease of packaging efficiency due to the reduced size of FSV mutants, although avian sarcoma virus UR2 has been found to possess a genome much smaller than those of P34 and P1 mutants of FSV (34) . It seems most likely that deletion mutagenesis in these mutants may have resulted in some modification in the structure of FSV-P130 necessary for cell transformation. Tyrosine-specific protein kinase activity associated with FSV-P130 appears to be intact in these mutants, at least on the basis of the in vitro autophosphorylation reaction (Fig. 5) . Therefore, some properties of FSV-P130 other than tyrosine kinase activity, possibly those required for association of this protein with cellular components or important for interaction with the proper targets of the kinase activity in CEFs, might be inappropriate for high oncogenicity. Similar cases in which sequences outside the kinase domain of oncogenes have a crucial effect on the biological properties have been reported in pp60fs (4, 9, 23, 25) , p68erbB (55) , and P120yag-abl (39, 46 for the results of insertion of amino acids into proteins, we might find an additional or unexpected effect on the structure and the enzymological activity of the original proteins. Therefore, we consider that both analyses of deletion and insertion mutagenesis are necessary to examine the fine domain structure of proteins.
Other avian sarcoma viruses, Y73 and UR2, which are highly oncogenic in the chicken system have been found to have no transforming potential on rat 3Y1 cells in a DNA transfection system (M. Shibuya, unpublished data). A similar mechanism might be involved in the poor oncogenicity of the P34-and P1-FSV mutants, Y73 and UR2 avian sarcoma viruses, on rodent cells. 
